Elite Pharmaceuticals, Inc. Accrued Bonuses, Current
Elite Pharmaceuticals, Inc. (ELTP) had Accrued Bonuses, Current of $1.58 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Bonuses, Current $1.58M.
- 2026-03-31: Accrued Bonuses, Current $5.29M.
- 2025-12-31: Accrued Bonuses, Current $533.82K.
- 2025-09-30: Accrued Bonuses, Current $498.84K.
| Period end | Accrued Bonuses, Current |
|---|---|
| 2026-06-30 | $1.58M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $5.29M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $533.82K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $498.84K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $554.50K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $121.89K 10-K · filed 2026-06-29 |
| 2024-12-31 | $619.37K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $559.25K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $370.87K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $206.22K 10-K · filed 2025-06-30 |
| 2022-12-31 | $37.50K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $131.25K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $56.25K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $143.00K 10-K · filed 2023-06-29 |